995:HKEXAnhui Expressway Company Limited Class H Analysis
Data as of 2026-09-09 - not real-time
HK$0.51
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At HKD 0.5100, ClouDr Group Limited shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it gained 2.0%. With RSI at 51.9 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near HKD 0.4800 and resistance around HKD 0.5550.
Analyst price targets sit 255.7% above the current price. Revenue is contracting at 29.5% on a -29.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 31.4%, a beta of 0.13 and a maximum drawdown of 66.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Analyst price targets sit 255.7% above the current price. Revenue is contracting at 29.5% on a -29.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 31.4%, a beta of 0.13 and a maximum drawdown of 66.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.74
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.74
- Analyst targets imply +255.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -29.8%
- Analyst targets imply +255.7% versus the current price
- Negative return on equity of -57.7%
Key Metrics & Analysis
Financial Health
Revenue Growth-29.50%
Profit Margin-29.77%
ROE-57.66%
ROA-0.66%
Debt/Equity127.03
P/B Ratio0.6
Industry P/E29.8
Technical Analysis
TrendBearish
RSI51.9
SupportHK$0.48
ResistanceHK$0.56
MA 20HK$0.50
MA 50HK$0.51
MA 200HK$0.74
MACDBullish
VolumeDecreasing
Fear & Greed Index92.52
Valuation
Target PriceHK$1.81
Upside/Downside255.70%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.13
Volatility31.41%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.